Evidence map›Paper›PMID 24039193›Full record

ArticleMolecular nutrition & food research2014

Synergistic induction of human cathelicidin antimicrobial peptide gene expression by vitamin D and stilbenoids.

Chunxiao Guo, Brian Sinnott, Brenda Niu, Malcolm B Lowry, Mary L Fantacone, Adrian F Gombart

Abstract read
In one paragraph

Article in Molecular nutrition & food research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Gut distress and interventionFrontiers in public health · 2023
    Pooled it
  2. Regular Supplementation With Resveratrol Improves Bone Mineral Density in Postmenopausal Women: A Randomized, Placebo-Controlled Trial.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2020
    Trial
  3. Article
  4. Review
  5. Article
  6. Regulation of Host Defense Peptide Synthesis by Polyphenols.Antibiotics (Basel, Switzerland) · 2023
    Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Review
  17. Vitamin D and the Host-Gut Microbiome: A Brief Overview.Acta histochemica et cytochemica · 2020
    Review
  18. Stilbenoids: A Natural Arsenal against Bacterial Pathogens.Antibiotics (Basel, Switzerland) · 2020
    Review
  19. A mouse model for vitamin D-induced human cathelicidin antimicrobial peptide gene expression.The Journal of steroid biochemistry and molecular biology · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Chunxiao Guo *Linus Pauling Institute, Oregon State University, Corvallis, Oregon 97331.
Brian Sinnott *Linus Pauling Institute, Oregon State University, Corvallis, Oregon 97331.
Brenda NiuSchool of Medicine, Oregon Health Sciences University, Portland, Oregon 97239.
Malcolm B LowryLinus Pauling Institute, Oregon State University, Corvallis, Oregon 97331.
Mary L FantaconeLinus Pauling Institute, Oregon State University, Corvallis, Oregon 97331.
Adrian F GombartLinus Pauling Institute, Oregon State University, Corvallis, Oregon 97331.
Oregon State University · USOregon Health & Science University · US

Funding

Regulating Cathelicidin Expression for Disease TherapyR01AI065604 · NIAID · OREGON STATE UNIVERSITY · PI GOMBART, ADRIAN FRIEDRICH · 2007 to 2011
$2.1M
NIAID NIH HHS 5R01AI65604NIAID NIH HHS R01 AI065604
6 · The paper itself

Abstract

scopeThe cathelicidin antimicrobial peptide (CAMP) gene is induced by 1α,25-dihydroxyvitamin D3 (1α,25(OH)2 D3), lithocholic acid, curcumin, nicotinamide, and butyrate. Discovering additional small molecules that regulate its expression will identify new molecular mechanisms involved in CAMP regulation and increase understanding of how diet and nutrition can improve immune function. METHODS AND

resultsWe discovered that two stilbenoids, resveratrol and pterostilbene, induced CAMP promoter-luciferase expression. Synergistic activation was observed when either stilbenoid was combined with 1α,25(OH)2 D3. Both stilbenoids increased CAMP mRNA and protein levels in the monocyte cell line U937 and synergy was observed in both U937 and the keratinocyte cell line, HaCaT. Inhibition of resveratrol targets sirtuin-1, cyclic AMP production and the c-Jun N-terminal, phosphoinositide 3 and AMP-activated kinases did not block induction of CAMP by resveratrol or synergy with 1α,25(OH)2 D3. Nevertheless, inhibition of the extracellular signal regulated 1/2 and p38 mitogen-activated protein kinases, increased CAMP gene expression in combination with 1α,25(OH)2 D3 suggesting that inhibition of these kinases by resveratrol may explain, in part, its synergy with vitamin D.

conclusionOur findings demonstrate for the first time that stilbenoid compounds may have the potential to boost the innate immune response by increasing CAMP gene expression, particularly in combination with 1α,25(OH)2 D3.

Indexed as

Antimicrobial Cationic PeptidesCathelicidinsCell LineCyclic AMPDrug Evaluation, PreclinicalDrug SynergismGene Expression RegulationHumansp38 Mitogen-Activated Protein KinasesResveratrolSignal TransductionSirtuin 1Small Molecule LibrariesStilbenesVitamin DAntimicrobial Cationic PeptidesCathelicidinsCyclic AMPdihydroxy-vitamin D3p38 Mitogen-Activated Protein KinasespterostilbeneResveratrolSIRT1 protein, humanSirtuin 1Small Molecule LibrariesStilbenesVitamin DCathelicidin antimicrobial peptideInnate immunityResveratrolStilbenoidVitamin D receptor

Identifiers

PMID24039193
PMCPMC3947465
OpenAlexW1963620746

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.